Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 5, 2002, Pages 1479-1484

  Ran, Sophia ^a,b   Thorpe, Philip E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Apoptosis; Phosphatidylserine; Reactive oxygen species; Tumor endothelium; Tumor targeting

Indexed keywords

ACIDITY; CELLS; HYDROGEN PEROXIDE; MEDICAL IMAGING; MONOCLONAL ANTIBODIES; TISSUE CULTURE; TUMORS;

TUMOR VASCULATURES;

ONCOLOGY;

ANTIBODY; CASPASE 3; IODINE 125; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE;

ANIMAL CELL; APOPTOSIS; CANCER THERAPY; CELL ASSAY; CELL CULTURE; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; EXPOSURE; FROZEN SECTION; HUMAN; HUMAN CELL; HYPOXIA; IMAGING; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; REOXYGENATION; SOLID TUMOR; TISSUE CULTURE; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANNEXIN A5; ANOXIA; ANTIBODIES; APOPTOSIS; CASPASE 3; CASPASES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; IN SITU NICK-END LABELING; MICE; NEOPLASMS; OXIDATIVE STRESS; OXYGEN; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES;

EID: 0036891466     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03928-7     Document Type: Conference Paper

References (32)

1. Williamson P., Schlegel R.A. Back and forth The regulation and function of transbilayer phospholipid movement in eukaryotic cells . Mol Membr Biol. 11:1994;199-216.
2. Zwaal R.F., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 89:(4):1997;1121-1132.
3. Devaux P.F. Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct. 21:1992;417-439.
4. Comfurius P., Senden J.M., Tilly R.H., et al. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta. 1026:(2):1990;153-160.
5. Zhou Q., Zhao J., Stout J.G., Luhm R.A., Wiedmer T., Sims P.J. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem. 272:1997;18240-18244.
6. Blankenberg F.G., Katsikis P.D., Tait J.F., et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 95:(11):1998;6349-6354.
7. Bombeli T., Karsan A., Tait J.F., et al. Apoptotic vascular endothelial cells become procoagulant. Blood. 89:1997;2429-2442.
8. Herrmann A., Devaux P.F. Alteration of the aminophospholipid translocase activity during in vivo and artificial aging of human erythrocytes. Biochim Biophys Acta. 1027:(1):1990;41-46.
9. Sessions A., Horwitz A.F. Myoblast aminophospholipid asymmetry differs from that of fibroblasts. FEBS Lett. 134:(1):1981;75-78.
10. Adler R., Ng A.-K., Rote N.S. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod. 53:(4):1995;905-910.
11. Vogt E., Ng A.-K., Rote N.S. A model for the antiphospholipid antibody syndrome Monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice . Am J Obstet Gynecol. 174:(2):1996;700-707.
12. Rote N.S., Ng A.-K., Dostal-Johnson D.A., et al. Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation. Clin Immunol Immunopathol. 66:1993;193-200.
13. Demo S.D., Masuda E., Rossi A.B., et al. Quantitative measurement of mast cell degranulation using a novel flow cytomeric annexin-V binding assay. Cytometry. 36:(4):1999;340-348.
14. Qu J., Conroy L.A., Walker J.H., et al. Phosphatidylserine-mediated adhesion of T-cells to endothelial cells. Biochem J. 317:(pt. 2):1996;343-346.
15. Lupu F., Moldovan N., Ryan J., et al. Intrinsic procoagulant surface induced by hypercholestrolaemia on rabbit aortic endothelium. Blood Coagul Fibrinolysis. 4:(5):1993;743-752.
16. van Geelen A.G., Slobbe-van Drunen M.E., Muller A.D., et al. Membrane related effects in endothelial cells induced by human cytomegalovirus. Arch Virol. 140:(9):1995;1601-1612.
17. Christiansen V.J., Sims P.J., Hamilton K.K. Complement C5b-9 increases plasminogen binding and activation on human endothelial cells. Arterioscler Thromb Vasc Biol. 17:(1):1997;164-171.
18. Julien M., Millot C., Tocanne J.F., et al. 12-O-tetradecanoylphorbol-13-acetate inhibits aminophospholipid translocase activity and modifies the lateral motions of fluorescent phospholipid analogs in the plasma membrane of bovine aortic endothelial cells. Exp Cell Res. 234:(1):1997;125-131.
19. Utsugi T., Schroit A.J., Connor J., et al. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res. 51:(11):1991;3062-3066.
20. Hinkovska-Galcheva V., Petkova D., Koumanov K. Changes in the phospholipid composition and phospholipid asymmetry of ram sperm plasma membranes after cryopreservation. Cryobiology. 26:(1):1989;70-75.
21. Ran S., Gao B., Duffy S., et al. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature. Cancer Res. 58:(20):1998;4646-4653.
22. Burrows F.J., Watanabe Y., Thorpe P.E. A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors. Cancer Res. 52:1992;5954-5962.
23. Lucas R., Garcia I., Donati Y.R., et al. Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur J Immunol. 28:(11):1998;3577-3586.
24. Krajewska M., Wang H.G., Krajewski S., et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 57:(8):1997;1605-1613.
25. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:(3):1992;493-501.
26. Rao L.V.M., Tait J.F., Hoang A.D. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res. 67:1992;517-531.
27. Hammill A.K., Uhr J.W., Scheuermann R.H. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res. 251:(1):1999;16-21.
28. Dillon S.R., Mancini M., Rosen A., et al. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol. 164:(3):2000;1322-1332.
29. Zhao J., Zhou Q., Wiedmer T., et al. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem. 273:1998;6603-6606.
30. Zulueta J.J., Yu F.S., Hertig I.A., et al. Release of hydrogen peroxide in response to hypoxia-reoxygenation Role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane . Am J Respir Cell Mol Biol. 12:(1):1995;41-49.
31. Shaughnessy S.G., Buchanan M.R., Turple S., et al. Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species. Am J Pathol. 134:(4):1989;787-796.
32. McEvoy L., Williamson P., Schlegel R.A. Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci U S A. 83:(10):1986;3311-3315.